Connect with us

National

Conservationists help tackle poaching in Hwange

Published

on

BY NOKUTHABA DLAMINI

Hwange National Park, once a favourite hunting ground for poachers, has not lost an elephant to the illegal hunters for the past two years largely because of partnerships between the Zimbabwe Parks and Wildlife Management Authority (Zimparks) and non-governmental organisations.

Advertisement

In 2013, over 300 elephants were killed by poachers at the country’s largest game reserve as the menace reached its peak.

Poachers, who included villagers from rural outposts such as Tsholotsho and Hwange used cyanide to kill the elephants for their ivory.

One of the major organisations that have joined hands with Zimparks to protect the animals in Hwange is Bhejani Trust, which also operates at the Zambezi National Park and Kazuma Pan National Park in Matabeleland North.

Advertisement

Bhejane Trust director Trevor Lane said the last elephant poaching incident at the Hwange National Park was in 2020 and he attributed the  of the anti-poaching activities to the partnerships between Zimparks and conservation groups.

“Efforts by (Zimparks) and what we do differently to promote conservation in the region has positively impacted on conservation of our wildlife, especially elephants which frequently strayed out of national parks into communal areas to search for food and water,” Lane said.

“As an organisation ours is to ensure that our wildlife has adequate water supply because generally where we operate natural water is drying up fast during the summer and the pressure of elephants all coming together.

Advertisement

“We are faced with a challenge of keeping up with the demand in order for us to keep them inside the parks.

“Every year we have managed to put in a few more water pumps. We are trying to put in more pumps into the back area of Robins Camp because while there’s natural water, there’s a good population of elephants.

“But once that dries up the elephants are all forced to go forward to the existing pumps, which adds to the pressure. Some end up straying outside, leading to human wildlife conflict situations, that’s why we want to add more from the existing 49 to drive them back into the park.”

Advertisement

The organisation pumps one million litres of water per day, which is consumed by approximately 16 000 elephants out of the 44 000 found in the Hwange National Park

Another fruitful partnership for Zimparks is with the international Fund for Animal Welfare (IFAW), which recently set up a new ranger station in the Makona area of Hwange National Park to strengthen the fight against poachers.

IFAW said the ranger station will also help the communities living near the park, who have suffered from elephants and other large herbivores destroying their crops and predators killing their livestock.

Advertisement

“When complete, the camp will be home to 56 rangers and their families who will live and work there,” IFAW said in a statement.

“Comfortable housing, equipped with electricity and running water, is being built for junior rangers and senior staff, and a recreation centre is under construction.

The operations centre is already in use and set up with a landscape-wide VHF radio network—vital communications equipment that connects rangers and improves responses to incidents of poaching.”

Advertisement

IFAW said before the camp was constructed responses to poaching incidents and reaction to reports on problem animals were slow, with rangers being deployed from Hwange Main Camp, some 95 kilometres away and enduring a terrible road snaking through the sticky Kalahari sands.

Augustine Gomba, Zimparks’ wildlife cfficer based at Hwange Main Camp, said before the road was developed, driving to Makona was a nightmare.

“The sandy soils and the rugged nature of the road meant that on average the trip to Makona would take a grueling four hours at least,” Gomba said.

Advertisement

A key achievement of the IFAW-Zimparks agreement was the improvement of the road, cutting a journey that could take up to four hours down to less than two.

The park is nestled on the edge of the Kalahari Desert and is home to some of Africa’s most iconic species.

Being largely flat and dominated by scattered woodlands of teak trees, it was an easy target for poachers.

Advertisement

“The new ranger station will prevent poachers from entering Hwange National Park into the future, allowing the park’s elephants and other wildlife to continue to flourish,” IFAW said.

Zimparks struggles to fund conservation efforts due to poor funding. – The Standard

Advertisement
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

National

World AIDS Day: UN Chief says ending AIDS by 2030 “is within grasp”

Published

on

BY SONIA HLOPHE

United Nations Secretary-General António Guterres has marked World AIDS Day with a message urging world leaders to scale up investment, confront stigma and ensure that lifesaving HIV services reach everyone who needs them.

Advertisement

In his statement, Guterres said this year’s commemoration serves as a reminder that the world “has the power to transform lives and futures, and end the AIDS epidemic once and for all.”

He highlighted the major gains achieved over the past decade.

“The progress we have made is undeniable,” he said, noting that “since 2010, new infections have fallen by 40 per cent” while “AIDS-related deaths have declined by more than half.” Access to treatment, he added, “is better than ever before.”

Advertisement

But despite this global progress, the Secretary-General warned that the crisis is far from over.

“For many people around the world, the crisis continues,” he said. “Millions still lack access to HIV prevention and treatment services because of who they are, where they live or the stigma they endure.”

Guterres also raised concern over shrinking resources:

Advertisement

“Reduced resources and services are putting lives at risk and threatening hard-won gains.”

He said ending AIDS requires fully supporting communities, scaling up prevention and ensuring treatment for everyone.

“Ending AIDS means empowering communities, investing in prevention and expanding access to treatment for all people.”

Advertisement

He also called for innovation to be matched by real-world delivery:

“It means uniting innovation with action, and ensuring new tools like injectables reach more people in need.”

Above all, he stressed the need for a human-rights centred response so no one is excluded.

Advertisement

“At every step, it means grounding our work in human rights to ensure no one is left behind.”

With the 2030 global deadline approaching, the UN chief said success is still possible if momentum is sustained.

“Ending AIDS as a public health threat by 2030 is within grasp. Let’s get the job done.”

Advertisement

 

Advertisement
Continue Reading

National

Zimbabwe fast-tracks approval of long-acting HIV prevention drug Lenacapavir

Published

on

BY WANDILE TSHUMA

Zimbabwe has taken a major step in the fight against HIV following the rapid approval of Lenacapavir, a groundbreaking long-acting injectable for HIV pre-exposure prophylaxis (PrEP). The Medicines Control Authority of Zimbabwe (MCAZ) authorised the drug in just 23 days, marking one of the fastest regulatory approvals in the country’s history.

Advertisement

The application, submitted by pharmaceutical company Gilead Sciences in October, underwent an expedited review because of its public health importance. MCAZ says the fast-tracked process did not compromise scientific scrutiny, with the product subjected to a rigorous assessment of its safety, efficacy and quality.

Lenacapavir is designed for adults and adolescents weighing at least 35kg who are HIV-negative but at substantial risk of infection. Unlike traditional daily oral PrEP, the medicine is administered as a six-monthly injection, following an initiation phase that includes one injection and oral tablets on Days 1 and 2. Health authorities say this long-acting formulation could dramatically improve adherence and expand prevention options, particularly for communities where daily pill-taking is difficult.

MCAZ Director-General  Richard T. Rukwata described the approval as a landmark moment in Zimbabwe’s HIV response.

Advertisement

“The rapid approval of Lenacapavir reflects MCAZ’s dedication to accelerating access to trusted, high-quality health products. This milestone brings new hope for HIV prevention and reinforces our commitment to safeguarding public health,” he said.

To fast-track the process, the Authority applied a regulatory reliance approach, drawing on scientific assessments from the World Health Organization’s Prequalification Programme (WHO PQ). This allowed evaluators to build on internationally recognised review processes while ensuring Zimbabwe’s own standards were met.

The introduction of Lenacapavir comes as Zimbabwe continues efforts to reduce new HIV infections, particularly among young people and key populations who face barriers to consistent PrEP use. Public health experts say the drug’s twice-yearly dosing could be a game changer in improving uptake and protection.

Advertisement

MCAZ says it remains committed to ensuring Zimbabweans have access to safe, effective and good-quality medical products, in line with its mandate under the Medicines and Allied Substances Control Act.

Advertisement
Continue Reading

National

Zimbabwe makes gains against TB

Published

on

BY WANDILE TSHUMA

The World Health Organization (WHO) data show that Zimbabwe continues to make measurable gains in its fight against tuberculosis (TB).

Advertisement

According to the Global Tuberculosis Report 2025, Zimbabwe’s estimated TB incidence has declined to 203 per 100,000 population, representing a 3.8 % reduction from 2023. The report states that “TB incidence in Zimbabwe has fallen to 203 per 100 000, a 3.8 % reduction from 2023.” 

On treatment outcomes, the country’s overall success rate for all forms of TB has improved to 91 %, up from 89 % in 2023. The report quotes: “Treatment success for all forms of TB has improved to 91 %, up from 89 % in 2023.” 

For drug-resistant TB (DR-TB), progress has also been recorded: treatment success rose from 64 % for the 2021 cohort to 68 % for the 2022 cohort. As the report notes: “treatment success for drug-resistant TB increased from 64 % for the 2021 cohort to 68 % for the 2022 cohort.” 

Advertisement

In the critical sphere of TB‐HIV co-infection, Zimbabwe saw a drop in the co‐infection rate to 49 %, down from 51 %. The report states: “TB/HIV co-infection rates have fallen to 49 %, down from 51 %.” 

Zooming out, the 2025 global report shows that across the world TB is falling again, although not yet at the pace required to meet targets. Globally, incidence declined by almost 2 % between 2023 and 2024, and deaths fell around 3 %. 

However, the report warns that progress is fragile. Funding shortfalls, health-system disruptions (especially during the COVID-19 era), and the ongoing challenge of drug-resistant TB threaten to erode gains. The WHO page reminds that the 2025 edition “provides a comprehensive … assessment of the TB epidemic … at global, regional and country levels.” 

Advertisement

For example, although more people are being diagnosed and treated than in previous years, not enough are being reached with preventive interventions, and many countries are still far from the targets set under the End TB Strategy.

 

Advertisement
Continue Reading

Trending

Copyright © 2022 VicFallsLive. All rights reserved, powered by Advantage